This report aims to provide a comprehensive presentation of the global market for Diabetes Devices and Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices and Drugs. This report contains market size and forecasts of Diabetes Devices and Drugs in global, including the following market information:
Global Diabetes Devices and Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Devices and Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diabetes Devices Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Devices and Drugs include Medtronic, BD, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Bristol-Myers Squibb, DexCom, Companion Medical and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Devices and Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Devices and Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Devices and Drugs Market Segment Percentages, by Type, 2022 (%)
Diabetes Devices
Diabetes Drugs
Global Diabetes Devices and Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Devices and Drugs Market Segment Percentages, by Application, 2022 (%)
Diagnostic/Clinics
ICUs
Home Healthcare
Global Diabetes Devices and Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Devices and Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Devices and Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Devices and Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
BD
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Bristol-Myers Squibb
DexCom
Companion Medical
GlaxoSmithKline
Glenmark Pharmaceuticals
Novartis
Roche
Sanofi
MSD
Astrazeneca
Takeda
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Devices and Drugs, market overview.
Chapter 2: Global Diabetes Devices and Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetes Devices and Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Devices and Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Devices and Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Devices and Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Devices and Drugs Overall Market Size
2.1 Global Diabetes Devices and Drugs Market Size: 2022 VS 2029
2.2 Global Diabetes Devices and Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Devices and Drugs Players in Global Market
3.2 Top Global Diabetes Devices and Drugs Companies Ranked by Revenue
3.3 Global Diabetes Devices and Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Devices and Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Devices and Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Devices and Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Devices and Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Devices and Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Devices and Drugs Market Size Markets, 2022 & 2029
4.1.2 Diabetes Devices
4.1.3 Diabetes Drugs
4.2 By Type - Global Diabetes Devices and Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetes Devices and Drugs Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Devices and Drugs Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Devices and Drugs Market Size, 2022 & 2029
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Diabetes Devices and Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetes Devices and Drugs Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Devices and Drugs Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Devices and Drugs Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Devices and Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetes Devices and Drugs Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Devices and Drugs Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetes Devices and Drugs Revenue, 2018-2029
6.3.2 US Diabetes Devices and Drugs Market Size, 2018-2029
6.3.3 Canada Diabetes Devices and Drugs Market Size, 2018-2029
6.3.4 Mexico Diabetes Devices and Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetes Devices and Drugs Revenue, 2018-2029
6.4.2 Germany Diabetes Devices and Drugs Market Size, 2018-2029
6.4.3 France Diabetes Devices and Drugs Market Size, 2018-2029
6.4.4 U.K. Diabetes Devices and Drugs Market Size, 2018-2029
6.4.5 Italy Diabetes Devices and Drugs Market Size, 2018-2029
6.4.6 Russia Diabetes Devices and Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Diabetes Devices and Drugs Market Size, 2018-2029
6.4.8 Benelux Diabetes Devices and Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetes Devices and Drugs Revenue, 2018-2029
6.5.2 China Diabetes Devices and Drugs Market Size, 2018-2029
6.5.3 Japan Diabetes Devices and Drugs Market Size, 2018-2029
6.5.4 South Korea Diabetes Devices and Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Diabetes Devices and Drugs Market Size, 2018-2029
6.5.6 India Diabetes Devices and Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetes Devices and Drugs Revenue, 2018-2029
6.6.2 Brazil Diabetes Devices and Drugs Market Size, 2018-2029
6.6.3 Argentina Diabetes Devices and Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, 2018-2029
6.7.2 Turkey Diabetes Devices and Drugs Market Size, 2018-2029
6.7.3 Israel Diabetes Devices and Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetes Devices and Drugs Market Size, 2018-2029
6.7.5 UAE Diabetes Devices and Drugs Market Size, 2018-2029
7 Diabetes Devices and Drugs Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Diabetes Devices and Drugs Major Product Offerings
7.1.4 Medtronic Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Diabetes Devices and Drugs Major Product Offerings
7.2.4 BD Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Diabetes Devices and Drugs Major Product Offerings
7.3.4 Johnson & Johnson Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Diabetes Devices and Drugs Major Product Offerings
7.4.4 Abbott Laboratories Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Company Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Diabetes Devices and Drugs Major Product Offerings
7.5.4 Novo Nordisk Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.5.5 Novo Nordisk Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 DexCom
7.7.1 DexCom Company Summary
7.7.2 DexCom Business Overview
7.7.3 DexCom Diabetes Devices and Drugs Major Product Offerings
7.7.4 DexCom Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.7.5 DexCom Key News & Latest Developments
7.8 Companion Medical
7.8.1 Companion Medical Company Summary
7.8.2 Companion Medical Business Overview
7.8.3 Companion Medical Diabetes Devices and Drugs Major Product Offerings
7.8.4 Companion Medical Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.8.5 Companion Medical Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Diabetes Devices and Drugs Major Product Offerings
7.9.4 GlaxoSmithKline Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Glenmark Pharmaceuticals
7.10.1 Glenmark Pharmaceuticals Company Summary
7.10.2 Glenmark Pharmaceuticals Business Overview
7.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Major Product Offerings
7.10.4 Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.10.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Diabetes Devices and Drugs Major Product Offerings
7.11.4 Novartis Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 Roche
7.12.1 Roche Company Summary
7.12.2 Roche Business Overview
7.12.3 Roche Diabetes Devices and Drugs Major Product Offerings
7.12.4 Roche Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.12.5 Roche Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Diabetes Devices and Drugs Major Product Offerings
7.13.4 Sanofi Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 MSD
7.14.1 MSD Company Summary
7.14.2 MSD Business Overview
7.14.3 MSD Diabetes Devices and Drugs Major Product Offerings
7.14.4 MSD Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.14.5 MSD Key News & Latest Developments
7.15 Astrazeneca
7.15.1 Astrazeneca Company Summary
7.15.2 Astrazeneca Business Overview
7.15.3 Astrazeneca Diabetes Devices and Drugs Major Product Offerings
7.15.4 Astrazeneca Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.15.5 Astrazeneca Key News & Latest Developments
7.16 Takeda
7.16.1 Takeda Company Summary
7.16.2 Takeda Business Overview
7.16.3 Takeda Diabetes Devices and Drugs Major Product Offerings
7.16.4 Takeda Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.16.5 Takeda Key News & Latest Developments
7.17 North China Pharmaceutical Group Corporation
7.17.1 North China Pharmaceutical Group Corporation Company Summary
7.17.2 North China Pharmaceutical Group Corporation Business Overview
7.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Major Product Offerings
7.17.4 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.17.5 North China Pharmaceutical Group Corporation Key News & Latest Developments
7.18 Huadong Medicine
7.18.1 Huadong Medicine Company Summary
7.18.2 Huadong Medicine Business Overview
7.18.3 Huadong Medicine Diabetes Devices and Drugs Major Product Offerings
7.18.4 Huadong Medicine Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.18.5 Huadong Medicine Key News & Latest Developments
7.19 Dongbao Pharmaceutical
7.19.1 Dongbao Pharmaceutical Company Summary
7.19.2 Dongbao Pharmaceutical Business Overview
7.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Major Product Offerings
7.19.4 Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.19.5 Dongbao Pharmaceutical Key News & Latest Developments
7.20 Hisun Pharmacy
7.20.1 Hisun Pharmacy Company Summary
7.20.2 Hisun Pharmacy Business Overview
7.20.3 Hisun Pharmacy Diabetes Devices and Drugs Major Product Offerings
7.20.4 Hisun Pharmacy Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.20.5 Hisun Pharmacy Key News & Latest Developments
7.21 KELUN
7.21.1 KELUN Company Summary
7.21.2 KELUN Business Overview
7.21.3 KELUN Diabetes Devices and Drugs Major Product Offerings
7.21.4 KELUN Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.21.5 KELUN Key News & Latest Developments
7.22 Ginwa
7.22.1 Ginwa Company Summary
7.22.2 Ginwa Business Overview
7.22.3 Ginwa Diabetes Devices and Drugs Major Product Offerings
7.22.4 Ginwa Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.22.5 Ginwa Key News & Latest Developments
7.23 Tianan Pharmaceutical
7.23.1 Tianan Pharmaceutical Company Summary
7.23.2 Tianan Pharmaceutical Business Overview
7.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Major Product Offerings
7.23.4 Tianan Pharmaceutical Diabetes Devices and Drugs Revenue in Global Market (2018-2023)
7.23.5 Tianan Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Devices and Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetes Devices and Drugs Market Drivers in Global Market
Table 3. Diabetes Devices and Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetes Devices and Drugs in Global Market
Table 5. Top Diabetes Devices and Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Devices and Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Devices and Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Devices and Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Devices and Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Devices and Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Devices and Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetes Devices and Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Devices and Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Devices and Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Devices and Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Devices and Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Medtronic Company Summary
Table 31. Medtronic Diabetes Devices and Drugs Product Offerings
Table 32. Medtronic Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. BD Company Summary
Table 35. BD Diabetes Devices and Drugs Product Offerings
Table 36. BD Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. BD Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Diabetes Devices and Drugs Product Offerings
Table 40. Johnson & Johnson Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Diabetes Devices and Drugs Product Offerings
Table 44. Abbott Laboratories Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Diabetes Devices and Drugs Product Offerings
Table 48. Novo Nordisk Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Diabetes Devices and Drugs Product Offerings
Table 52. Bristol-Myers Squibb Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. DexCom Company Summary
Table 55. DexCom Diabetes Devices and Drugs Product Offerings
Table 56. DexCom Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. DexCom Key News & Latest Developments
Table 58. Companion Medical Company Summary
Table 59. Companion Medical Diabetes Devices and Drugs Product Offerings
Table 60. Companion Medical Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Companion Medical Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Diabetes Devices and Drugs Product Offerings
Table 64. GlaxoSmithKline Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Glenmark Pharmaceuticals Company Summary
Table 67. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product Offerings
Table 68. Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Glenmark Pharmaceuticals Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Diabetes Devices and Drugs Product Offerings
Table 72. Novartis Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Diabetes Devices and Drugs Product Offerings
Table 76. Roche Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Diabetes Devices and Drugs Product Offerings
Table 80. Sanofi Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. MSD Company Summary
Table 83. MSD Diabetes Devices and Drugs Product Offerings
Table 84. MSD Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. MSD Key News & Latest Developments
Table 86. Astrazeneca Company Summary
Table 87. Astrazeneca Diabetes Devices and Drugs Product Offerings
Table 88. Astrazeneca Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Astrazeneca Key News & Latest Developments
Table 90. Takeda Company Summary
Table 91. Takeda Diabetes Devices and Drugs Product Offerings
Table 92. Takeda Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Takeda Key News & Latest Developments
Table 94. North China Pharmaceutical Group Corporation Company Summary
Table 95. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product Offerings
Table 96. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. North China Pharmaceutical Group Corporation Key News & Latest Developments
Table 98. Huadong Medicine Company Summary
Table 99. Huadong Medicine Diabetes Devices and Drugs Product Offerings
Table 100. Huadong Medicine Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Huadong Medicine Key News & Latest Developments
Table 102. Dongbao Pharmaceutical Company Summary
Table 103. Dongbao Pharmaceutical Diabetes Devices and Drugs Product Offerings
Table 104. Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Dongbao Pharmaceutical Key News & Latest Developments
Table 106. Hisun Pharmacy Company Summary
Table 107. Hisun Pharmacy Diabetes Devices and Drugs Product Offerings
Table 108. Hisun Pharmacy Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Hisun Pharmacy Key News & Latest Developments
Table 110. KELUN Company Summary
Table 111. KELUN Diabetes Devices and Drugs Product Offerings
Table 112. KELUN Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. KELUN Key News & Latest Developments
Table 114. Ginwa Company Summary
Table 115. Ginwa Diabetes Devices and Drugs Product Offerings
Table 116. Ginwa Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Ginwa Key News & Latest Developments
Table 118. Tianan Pharmaceutical Company Summary
Table 119. Tianan Pharmaceutical Diabetes Devices and Drugs Product Offerings
Table 120. Tianan Pharmaceutical Diabetes Devices and Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Tianan Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Diabetes Devices and Drugs Segment by Type in 2022
Figure 2. Diabetes Devices and Drugs Segment by Application in 2022
Figure 3. Global Diabetes Devices and Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Devices and Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Devices and Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2022
Figure 8. By Type - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetes Devices and Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 16. US Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 28. China Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetes Devices and Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetes Devices and Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Medtronic Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BD Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novo Nordisk Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. DexCom Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Companion Medical Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Novartis Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Roche Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sanofi Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. MSD Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Astrazeneca Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Takeda Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Huadong Medicine Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Hisun Pharmacy Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. KELUN Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Ginwa Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Tianan Pharmaceutical Diabetes Devices and Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
